71 results
10-K
2023 FY
EX-10.16
MIRM
Mirum Pharmaceuticals Inc
Annual report
15 Mar 24
5:03pm
10-K
2023 FY
EX-10.4
MIRM
Mirum Pharmaceuticals Inc
Annual report
15 Mar 24
5:03pm
8-K
EX-10.1
tnnvk29jzw2
11 Sep 23
Departure of Directors or Certain Officers
4:16pm
8-K
EX-10.1
wdj6ogdn0molzr5m
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
jo3fttfe
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.2
mmxr329y27yaa
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.1
gmcjavbjg
9 Jan 23
Mirum Pharmaceuticals Announces Preliminary Unaudited LIVMARLI 2022 Net Revenue and Provides Corporate Updates
8:46am